Retinoic acid, acting as a highly specific IgA isotype switch factor, cooperates with TGF-β1 to enhance the overall IgA response

Retinoic acid, in cooperation with TGF‐β1, increases IgA class switching and expression of gut‐homing molecules CCR9 and α4β7, on mouse B cells. The present study demonstrates that RA has activity of an IgA switch factor and is more specific than TGF‐β1. RA independently caused only IgA switching, w...

Full description

Saved in:
Bibliographic Details
Published inJournal of leukocyte biology Vol. 94; no. 2; pp. 325 - 335
Main Authors Seo, Goo‐Young, Jang, Young‐Saeng, Kim, Hyun‐A, Lee, Mi‐Ra, Park, Mi‐Hee, Park, Seok‐Rae, Lee, Jeong‐Min, Choe, Jongseon, Kim, Pyeung‐Hyeun
Format Journal Article
LanguageEnglish
Published United States Society for Leukocyte Biology 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Retinoic acid, in cooperation with TGF‐β1, increases IgA class switching and expression of gut‐homing molecules CCR9 and α4β7, on mouse B cells. The present study demonstrates that RA has activity of an IgA switch factor and is more specific than TGF‐β1. RA independently caused only IgA switching, whereas TGF‐β1 caused IgA and IgG2b switching. We found that RA increased IgA production and that this was a result of its ability to increase the frequency of IgA‐secreting B cell clones. Increased IgA production was accompanied by an increase of GLTα. RA activity was abrogated by an antagonist of the RAR. Additionally, RA affected intestinal IgA production in mice. Surprisingly, RA, in combination with TGF‐β1, notably enhanced not only IgA production and GLTα expression but also CCR9 and α4β7 expression on B cells. These results suggest that RA selectively induces IgA isotype switching through RAR and that RA and TGF‐β have important effects on the overall gut IgA antibody response.
Bibliography:These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0741-5400
1938-3673
DOI:10.1189/jlb.0313128